Details for Patent: 6,746,691
✉ Email this page to a colleague
Summary for Patent: 6,746,691
Title: | Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics |
Abstract: | Intermediate release nicotinic acid formulations having unique biopharmaceutical characteristics, which are suitable for oral administration once per day as a single dose preferably administered during the evening or at night for treating hyperlipidemia without causing drug-induced hepatotoxicity to such a level that requires the therapy to be discontinued, are disclosed. The intermediate nicotinic acid formulations can be administered as tablets in dosage strengths of, for example, 375 mg, 500 mg, 750 mg and 1000 mg. The 375 mg, 500 mg and 750 mg nicotinic acid tablets of the present invention have a dissolution curve similarity fit factor F.sub.2 of at least about 79, and the 1000 mg nicotinic acid tablets of the present invention have a dissolution curve similarity fit factor F.sub.2 of at least 44. |
Inventor(s): | Cefali; Eugenio A. (Lauderhill, FL) |
Assignee: | Kos Pharmaceuticals, Inc. (Miami, FL) |
Application Number: | 08/962,424 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 6,746,691 |
Patent Claim Types: see list of patent claims | Use; Formulation; Compound; Dosage form; Device; |
Drugs Protected by US Patent 6,746,691
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,746,691
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 289197 | ⤷ Try a Trial | |||
Australia | 4751802 | ⤷ Try a Trial | |||
Australia | 6348198 | ⤷ Try a Trial | |||
Australia | 6454598 | ⤷ Try a Trial | |||
Australia | 775967 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |